D
Enliven Therapeutics, Inc. ELVN
$18.73 -$0.08-0.43% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 12.98% 75.14% 73.85% 58.23% 32.59%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 21.96% 25.51% 17.95% 30.63% 58.28%
Operating Income -21.96% -25.51% -17.95% -30.63% -58.28%
Income Before Tax -25.53% -19.67% -11.49% -17.92% -54.43%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -25.53% -19.67% -11.49% -19.31% -54.43%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -25.53% -19.67% -11.49% -19.31% -54.43%
EBIT -21.96% -25.51% -17.95% -30.63% -58.28%
EBITDA -22.04% -25.60% -18.01% -30.73% -58.45%
EPS Basic -5.45% 1.30% 5.24% -1.67% 32.00%
Normalized Basic EPS -5.44% -9.80% -1.08% -8.92% 31.99%
EPS Diluted -5.45% 1.30% 5.24% -1.67% 32.00%
Normalized Diluted EPS -5.44% -9.80% -1.08% -8.92% 31.99%
Average Basic Shares Outstanding 19.04% 21.23% 17.64% 17.37% 127.09%
Average Diluted Shares Outstanding 19.04% 21.23% 17.64% 17.37% 127.09%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --